Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Athelas has developed an FDA-cleared in-home blood diagnostic device ("Athelas One") that enables early detection of infections and immune changes from a drop of blood. The company also offers an AI-driven software suite for automating medical billing, documentation, scheduling, and telehealth workflows. Clinical results have demonstrated accuracy in white blood cell analysis comparable to lab-based methods.
The company merged with Commure in October 2023 to form a $6B healthcare infrastructure entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Athelas.